This is in agreement with findings in colorectal cancer, where Suzuki et al. 22 suggested that SFRP4 may not be an important inhibitor of the Wnt signalling pathway due to lower frequency of DNA hypermethylation and weaker Wnt signalling inhibition compared with other SFRP family members. This evidence concerns the gene SFRP4 and colorectal cancer.